{"name":"Dermax SA","slug":"dermax-sa","ticker":"","exchange":"","domain":"","description":"Dermax SA is a specialty pharmaceutical company focused on dermatological treatments, with a strong emphasis on developing and commercializing innovative therapies for skin conditions. The company has a limited public presence, but it is known for its two key products in Phase 3 development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Condylox Topical Gel 0.5%","genericName":"Condylox Topical Gel 0.5%","slug":"condylox-topical-gel-0-5","indication":"Genital warts (condylomata acuminata)","status":"phase_3"},{"name":"Podofilox Gel 0.5%","genericName":"Podofilox Gel 0.5%","slug":"podofilox-gel-0-5","indication":"Genital warts","status":"phase_3"}]}],"pipeline":[{"name":"Condylox Topical Gel 0.5%","genericName":"Condylox Topical Gel 0.5%","slug":"condylox-topical-gel-0-5","phase":"phase_3","mechanism":"Podophyllotoxin arrests cell division by disrupting microtubule formation, causing necrosis of genital wart tissue.","indications":["Genital warts (condylomata acuminata)"],"catalyst":""},{"name":"Podofilox Gel 0.5%","genericName":"Podofilox Gel 0.5%","slug":"podofilox-gel-0-5","phase":"phase_3","mechanism":"Podofilox is a plant-derived antimitotic agent that inhibits cell division.","indications":["Genital warts","Cervical intraepithelial neoplasia"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}